Vaccines Europe papers and publications (Update: July 2018)
Vaccine Europe position on the IPROVE Industry R&D priorities
Potential labelling/packaging improvements to facilitate vaccine supply
EFPIA, EBE and Vaccines Europe Back EU Leadership in Sustainable, Collaborative Fight Against AMR
Vaccines Europe priorities for vaccination policies in Europe
Towards a sustainable and integrated development and implementation of new prophylactic vaccines
Vaccines Europe position paper on Life-long immunisation
From vaccines shortages to sustainable vaccine supply
Role of vaccination in reducing antimicrobial resistance
Vaccines Europe position paper on Vaccines HTA
Reflection paper on the Safety Assessment of Residuals and Contaminants in Vaccines
Reply to the Green Paper on the modernisation of EU public procurement policy
General report on experience acquired as a result of the application of the paediatric regulation
VE industry vision on future R&D
Adult_Vaccination Key Component of Healthy Ageing (SAATI Report)
Attitudes to Vaccination Critical Review
EFPIA VE IMI2 Strategic Research Agenda
NITAG policies in developed countries – Vaccine
Strengthening NITAG policies – Vaccine
Infographics
Vaccines: a tool for spending smart
Prevention First: Vaccination at Heart of Public Health
The impact of influenza vaccination in the European Union
How long for a vaccine to reach European population? A Vaccines Europe study
The Vaccines Industry in figures
Vaccines’ contribution to Europe’s future
Other resources (events, external materials, etc.)
OECD presentations on Investment in Prevention (2013)
GMAS presentation on Benefits of Adult Immunisation (2013)
Gallery of Vaccines Europe Day 2013 (flickr)
